Wegovy vs Ozempic: Compare Differences & Prices

When considering Wegovy and Ozempic, it’s important to understand how their side effects compare—especially since both contain the same active medication, semaglutide. Because Wegovy is typically prescribed at a higher dose than Ozempic, people taking Wegovy may experience side effects more often or with greater intensity. Both drugs are given as weekly injections and work by mimicking a natural hormone that helps control blood sugar and appetite, but higher doses mean there’s a greater chance of feeling certain effects.

The most common side effects are similar for both medications and mainly affect the digestive system. People often report nausea, vomiting, diarrhea, constipation, and stomach pain when starting either drug. Other possible symptoms include bloating, indigestion, burping, and a general feeling of fullness that can reduce appetite. Some people also feel dizzy, tired, or experience headaches. The likelihood and severity of these side effects can increase as the dose is raised, which is why both drugs are started at a low dose and gradually increased over several weeks. Specific side effects that people may notice include:

• Nausea

• Diarrhea

• Vomiting

• Constipation

• Belly pain

• Indigestion

• Headache

• Dizziness

• Excess gas or bloating

• Fatigue

Rare but serious side effects may occur as well. Both Wegovy and Ozempic have been linked, in some cases, to inflammation of the pancreas (pancreatitis), and there may be a risk for gallbladder problems. People with a personal or family history of certain thyroid conditions, such as medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, are advised not to use these drugs. Another risk, especially for people with diabetes and existing eye disease, is the chance of worsening eye problems called retinopathy, particularly if blood sugar levels drop quickly. In studies, a small percentage of people taking Ozempic experienced new or worsening retinopathy. It is a good idea to have your eyes checked before starting, and see your eye doctor regularly if you have diabetes or pre-existing eye issues.

Appetite suppression and slowed movement of food through the stomach can, in rare cases, cause more serious digestive problems, like gastroparesis (“stomach paralysis”). While most cases of nausea or upset stomach get better with time, these medications may not be suitable for individuals with a history of severe stomach or gut issues. If symptoms are very bothersome or severe (such as persistent vomiting), medical attention may be needed. There have been rare reports of severe complications requiring hospitalization, but these are uncommon.

A significant point to consider is that not everyone tolerates these medications well. Side effects are one of the main reasons people decide to stop using Wegovy or Ozempic. Across different research studies, the rate at which people discontinue these drugs because of side effects varies, ranging from about 10% up to 20%. Some people find that unpleasant symptoms decrease with time or by remaining at a lower dose longer, while others may need to stop or switch medications. Before starting, be sure to discuss your full medical history and any concerns with your healthcare provider, as they can help you weigh the risks and benefits, offer strategies to manage side effects, and decide if one medication may suit you better than the other.

Overall, choosing between Wegovy and Ozempic for weight loss or diabetes management is a personal decision that involves more than just potential for weight loss—it also includes weighing the likelihood and impact of side effects, cost, insurance coverage, your health history, and your ability to stick with a weekly injection long-term. Open communication with your doctor and regular follow-up appointments are important for maximizing benefits while minimizing risks.

Wegovy and Ozempic are both injectable medications that contain semaglutide, but they are approved by health authorities to treat different conditions and for different groups of people. Understanding what each drug is intended to treat is important when considering which one might be right for you.

Ozempic is approved for adults who have type 2 diabetes. Its main purpose is to help control blood sugar levels when diet and exercise alone are not enough. Ozempic can also lower the risk of major heart problems such as heart attack or stroke, but only in adults who already have both type 2 diabetes and established cardiovascular disease. It is not designed for, nor approved to manage, blood sugar in people with type 1 diabetes or for those who simply have a higher risk of heart problems without a history of heart disease.

Wegovy, on the other hand, is approved specifically for weight management. Its use is limited to adults and adolescents aged 12 and older who meet certain criteria. For adults, Wegovy is an option if you have obesity (a body mass index, or BMI, of 30 or greater), or if you have overweight (BMI of 27 or greater) with at least one weight-related health problem such as high blood pressure, type 2 diabetes, or high cholesterol. For teenagers, Wegovy can be prescribed if they are 12 years of age or older and have obesity, defined in this age group as a BMI at or above the 95th percentile for their age and sex. Additionally, Wegovy is approved to help reduce the risk of serious heart problems like heart attack or stroke in adults who have overweight or obesity, whether or not they have diabetes.

Here is a summary of who can be treated with each medication:

Ozempic is approved for:

• Adults with type 2 diabetes, to improve blood sugar levels.

• Adults with type 2 diabetes and a history of established heart disease, to reduce the risk of major cardiovascular problems.

Wegovy is approved for:

• Adults with obesity (BMI ≥ 30).

• Adults with overweight (BMI ≥ 27) and at least one other weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol.

• Adolescents aged 12 and older with obesity (BMI at or above the 95th percentile for their age and sex).

• Adults at risk for heart attack or stroke who have overweight or obesity, even without diabetes.

It’s important to note that while both medications contain the same active ingredient, they shouldn’t be used interchangeably for all conditions. Ozempic is commonly used off-label for weight loss in people who do not have diabetes, but this is not an FDA-approved use. Similarly, if a person with diabetes were to use Wegovy specifically to lower their blood sugar, that would be considered off-label because Wegovy’s official approval does not include blood sugar management as a primary goal.

Before starting any of these medications, it is essential to talk to your healthcare provider. They will consider your medical history, your health conditions, and the specific approval status of each medication to help you choose the most appropriate and safe option for your needs. Using these drugs outside of their approved uses may lead to higher costs, as insurance is less likely to cover off-label prescriptions, and their safety and effectiveness in those situations are less certain.